Biomind Labs Inc. (OTCPK: BMND.F)
Health Care · Pharmaceuticals · CA
$—
— today · — 1Y
Biomind Labs Inc. (OTCPK: BMND.F) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $35.68M.
trading between 0.01 and 0.80.
Tweenvest scores Biomind Labs Inc. across four factors: quality 16/100, value 56/100. Its strongest factor is value.
BMND.F price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $35.68M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.02
- Dividend yield
- —
- Beta (5Y)
- 7.22
- 52-week high
- $0.80
- 52-week low
- $0.01
- Avg volume (3M)
- —
- Shares outstanding
- 77.57M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Anxo Pharmaceutical Co., Ltd.TPEX: 6677 | $35.93M | NT$20.50 | +7.89% |
| Corline Biomedical ABOM: CLBIO | $35.81M | Skr13.70 | 0.00% |
| Nippon Chemiphar Co., Ltd.TSE: 4539 | $35.79M | ¥1,564.00 | -0.57% |
| Beit Jala Pharmaceutical CompanyPLSE: BJP | $35.75M | JD— | — |
| Astonea Labs LimitedBSE: 544409 | $35.19M | Rs324.00 | -6.09% |
| Molecure S.A.WSE: MOC | $35.02M | zł6.61 | -0.75% |
| Prince Pharmaceutical Co., Ltd.TPEX: 6935 | $33.34M | NT$28.50 | +0.18% |
| Navamedic ASAOB: NAVA | $33.34M | Nkr13.30 | -0.37% |
Figures last refreshed Oct 11, 2026.